Donald A Bergstrom's Net Worth
$13.1 Million
Who is Donald A Bergstrom?
Donald A Bergstrom has an estimated net worth of $13.1 Million. This is based on reported shares across multiple companies, which include Relay Therapeutics, Inc., Fusion Pharmaceuticals Inc., and Mersana Therapeutics, Inc..
SEC CIK
Donald A Bergstrom's CIK is 0001709772
Past Insider Trading and Trends
2022 was Donald A Bergstrom's most active year for acquiring shares with 18 total transactions. Donald A Bergstrom's most active month to acquire stocks was the month of May. 2022 was Donald A Bergstrom's most active year for disposing of shares, totalling 39 transactions. Donald A Bergstrom's most active month to dispose stocks was the month of August. 2021 saw Donald A Bergstrom paying a total of $174,037.04 for 198,239 shares, this is the most they've acquired in one year. In 2021 Donald A Bergstrom cashed out on 173,079 shares for a total of $4,353,062.62, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Relay Therapeutics, Inc. (RLAY) Snapshot price: $9.13
President, R&D
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.51% | -2.69K |
$6.38 | -$17,136.68 | 527.43K |
Apr 29
| |||
Form 4
| -0.14% | -765.00 |
$7.70 | -$5,890.50 | 530.11K |
Mar 27
| |||
Form 4
| -0.60% | -3.18K |
$9.64 | -$30,635.92 | 530.88K |
Jan 29
| |||
Form 4
| +128.17% | 300K |
—
|
—
| 534.06K |
Jan 16
| |||
Form 4
| -0.42% | -977.00 |
$11.51 | -$11,245.27 | 234.06K |
Dec 27
| |||
Form 4
| -1.45% | -3.45K |
$6.03 | -$20,809.53 | 235.03K |
Oct 30
| |||
Form 4
| +0.12% | 580 |
$9.53 | $7,684.80 | 480.3K |
Jun 30 - Sep 27
| |||
Form 4
| -1.12% | -2.68K |
$11.80 | -$31,659.40 | 237.9K |
Jul 28
| |||
Form 4
| -0.27% | -647.00 |
$12.12 | -$7,841.64 | 240.59K |
Jun 27
| |||
Form 4/A
| -1.17% | -2.85K |
$11.16 | -$31,806.00 | 241.23K |
Apr 28
| |||
Form 4
| -0.57% | -1.38K |
$11.16 | -$15,434.28 | 242.7K |
Apr 28
| |||
Form 4
| -0.31% | -763.00 |
$15.36 | -$11,719.68 | 244.08K |
Mar 27
| |||
Form 4
| -0.58% | -1.43K |
$21.56 | -$30,809.24 | 244.85K |
Jan 30
| |||
Form 4
| +186.75% | 160.39K |
—
|
—
| 246.28K |
Jan 17
| |||
Form 4
| -1.13% | -980.00 |
$14.49 | -$14,200.20 | 85.89K |
Dec 27
| |||
Form 4
| -2.05% | -1.82K |
$13.33 | -$188,178.18 | 86.87K |
Scheduled
|
Oct 28 - Nov 1
| ||
Form 4
|
—
|
0
|
$13.28 | -$146,480.00 | 88.68K |
Scheduled
|
Oct 3
| ||
Form 4
| -1.09% | -976.00 |
$22.73 | -$22,184.48 | 88.68K |
Sep 27
| |||
Form 4
|
—
|
0
|
$17.06 | -$647,000.00 | 89.66K |
Scheduled
|
Sep 8
| ||
Form 4
|
—
|
0
|
$14.79 | -$104,566.00 | 89.66K |
Scheduled
|
Sep 2
| ||
Form 4
|
—
|
0
|
$13.60 | -$153,495.00 | 89.66K |
Scheduled
|
Sep 1
| ||
Form 4
|
—
|
0
|
$14.56 | -$313,200.00 | 89.66K |
Scheduled
|
Aug 24
| ||
Form 4
|
—
|
0
|
$12.06 | -$127,040.00 | 89.66K |
Scheduled
|
Aug 5
| ||
Form 4
| -2.01% | -1.83K |
$21.27 | -$39,030.45 | 89.66K |
Jul 28
| |||
Form 4
|
—
|
0
|
$12.06 | -$127,040.00 | 91.49K |
Scheduled
|
Jul 6
| ||
Form 4
| -1.08% | -1.00K |
$12.08 | -$147,329.69 | 91.49K |
Scheduled
|
Jun 24 - Jun 27
| ||
Form 4
| -1.92% | -1.81K |
$14.43 | -$312,807.27 | 92.49K |
Scheduled
|
Apr 28 - May 2
| ||
Form 4
|
—
|
0
|
$17.22 | -$471,600.00 | 94.3K |
Scheduled
|
Apr 1
| ||
Form 4
| -0.66% | -622.00 |
$29.87 | -$18,579.14 | 94.3K |
Mar 29
| |||
Form 4
|
—
|
0
|
$17.06 | -$258,800.00 | 94.93K |
Scheduled
|
Mar 24
| ||
Form 4
|
—
|
0
|
$14.56 | -$208,800.00 | 94.93K |
Scheduled
|
Mar 10
| ||
Form 4
|
—
|
0
|
$14.00 | -$158,080.00 | 94.93K |
Scheduled
|
Mar 1
| ||
Form 4
| -13.64% | -14.99K |
$12.53 | -$448,616.92 | 94.93K |
Scheduled
|
Feb 22
| ||
Form 4
| +144.43% | 64.95K |
—
|
—
| 109.92K |
Jan 27
| |||
Form 4
| -1.42% | -649.00 |
$33.10 | -$21,481.90 | 44.97K |
Dec 27
| |||
Form 4
| -39.67% | -30.00K |
$34.15 | -$1,024,500.00 | 45.62K |
Scheduled
|
Oct 15
| ||
Form 4
| -0.85% | -646.00 |
$36.87 | -$23,818.02 | 75.62K |
Sep 27
| |||
Form 4
| -1.26% | -976.00 |
$35.81 | -$34,950.56 | 76.27K |
Jun 28
| |||
Form 4
|
—
|
0
|
$18.93 | -$1,251,630.46 | 77.24K |
Scheduled
|
Jun 16
| ||
Form 4
| -42.17% | -56.32K |
$32.36 | -$1,822,644.64 | 77.24K |
Scheduled
|
Apr 16
| ||
Form 4
| +35.51% | 35K |
—
|
—
| 133.56K |
Mar 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Fusion Pharmaceuticals Inc. (FUSN) Snapshot price: $11.8
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Mersana Therapeutics, Inc. (MRSN) Snapshot price: $3.55
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||